Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

94 Annual Financial Statement Konzern-Jahresabschluss
Risks and unforeseeable developments
Concentration on aesthetics, development of photo-dynamic procedures
biolitec AG’s core business is currently the manufacture and sale of lasers and laser probes. The company
sees especially high growth potential in the area of aesthetics, which bundles lasers, optical fibers,
probes and eventually at a later stage photosensitizer to form an integrated treatment method. With the
EMEA approved photosensitizer Foscan® biolitec is the only supplier worldwide for PDT in the field of
oncology that offers all relevant core competencies – photosensitizer, lasers and optical fibers. The sale
of photosensitizer, however, is yet at an earlier stage. For this reason the company will only be able to
generate the targeted sales and earnings if sales of Foscan® for the treatment of head and neck cancer
is going to show a positive development and if it is able to successfully perform the clinical studies for
the developed products in order to gain approval for its use in the treatment of miscellaneous diseases
using PDT. In particular the achieved results in the aesthetics area, with the treatment of lipoma and
cellulite must be underpinned by detailed clinical studies.
A failure to meet the company’s expectations in the application possibilities or the medical effectiveness
of the methods would negatively affect the financial situation and the profit of biolitec. Same
would be valid in case of problems with or delays in the registration of products.
With the active substance Temoporfin and the pharmaceutical Foscan®, which were integrated within
the scope of an asset deal into the product portfolio in the financial year 2001/2002, increasing sales in
the European core market were achieved in the last fiscal year. Essential undershooting of the plan figures
would clearly effect the financial situation and profit.
The business activities of the biolitec group are to be further expanded and be made international.
Therefore, existing markets, above all in Asia, must be strengthened and others in new European countries
must be opened.
The entry into new markets, as for example Brazil and China with the necessary adaptation to the respective
circumstances of the countries and in particular the development of personnel resources
which are familiar with the respective markets and possess the necessary know-how are risks for the
future financial situation and profit of the group.